New combination approved by MFDS for s-amlodipine/valsartan

Published: 2013-08-14 06:57:00

Updated: 2013-08-14 06:57:00

Ahngook Pharm said on Tuesday that the Ministry of Food and Drug Safety (MFDS) had given the green light to Levosartan, which combines the two most commonly prescribed hypertension medicines in one tablet (5mg/160mg, 2.5mg/160mg and 2.5mg/80mg), and that it would be available from October.

Le...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK